Clinical Trial Update: Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) [Phase 2]

View source ↗

Summary

A Phase 2 exploratory study evaluating multiple regimens of Natalizumab in adults with Relapsing-Remitting Multiple Sclerosis has completed. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Natalizumab (Tysabri) (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2015-07-29